Topics

Vividion Secures $82 Million to Advance Its Lead Programs into the Clinic

20:00 EDT 29 Apr 2019 | BioSpace

For Vividion, the financing round comes about a year after the company forged a $101 million collaboration with Celgene.

Original Article: Vividion Secures $82 Million to Advance Its Lead Programs into the Clinic

NEXT ARTICLE

More From BioPortfolio on "Vividion Secures $82 Million to Advance Its Lead Programs into the Clinic"

Quick Search

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...